
Hikal
Update in progressHIKAL.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Hikal Limited and its subsidiaries manufacture and sell chemical intermediates, specialty chemicals, and active pharma ingredients for pharmaceutical, biotech, life sciences, animal health, crop protection, and specialty chemical industries. It operates through Pharmaceuticals and Crop Protection segments, offers contract research, custom synthesis and manufacturing, and exports worldwide. Based in Navi Mumbai, it was formerly Hikal Chemical Industries Ltd and renamed in 2000.
Company score
- Sentiment
- -0.14
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.10
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.01
- Governance
- -0.17
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.07
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!